Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sandra M. Geletko"'
Publikováno v:
Pharmacotherapy. 20:1129-1134
Recombinant human growth hormone (rhGH) is an important treatment option for patients with human immunodeficiency virus (HIV) wasting syndrome. Side effects of rhGH are minimal when administered at physiologic and moderately high dosages, as seen in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c13f7f168c44e6b47d1137eb442a3d4
https://doi.org/10.1592/phco.20.13.1129.35037
https://doi.org/10.1592/phco.20.13.1129.35037
Autor:
Fiore T, Kenneth H. Mayer, Frances A. Bettencourt, Michael N. Dudley, Marisel Segarra, Timothy P. Flanigan, Sandra M. Geletko
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:1338-1341
Several prophylactic medications for opportunistic or recurrent infections are used in human immunodeficiency virus-infected individuals. Essential to the efficacy evaluation of these agents is the accurate reporting of medication compliance. We hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1907118ca8e1e2291fe90e05367b908
https://doi.org/10.1128/aac.40.6.1338
https://doi.org/10.1128/aac.40.6.1338
Publikováno v:
Journal of Pharmacy Technology. 12:105-108
Objective: To measure and compare medication compliance by patient reports, pill counts, physician assessments, and electronic monitoring with the Medication Event Monitoring System (MEMS) in patients infected with HIV. Methods: Five patients monitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec4315ebfa71071fdbf13e5c62789d67
https://doi.org/10.1177/875512259601200309
https://doi.org/10.1177/875512259601200309
Autor:
Sanjeev Kaul, Marcia J. Browne, Kenneth H. Mayer, Michael N. Dudley, Lisa M. Dunkle, Kathleen K. Graham, Sandra M. Geletko
Publikováno v:
Journal of Infectious Diseases. 166:480-485
The pharmacokinetics of stavudine (d4T; 2',3'-didehydro-3'-deoxythymidine) were studied in patients with AIDS-related complex or AIDS enrolled in a dose-ranging phase I/II study. Twenty-two patients were studied after the first oral dose of 0.67, 1.3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c4a4c493c48a87de0fe2dc5e3b463ed
https://doi.org/10.1093/infdis/166.3.480
https://doi.org/10.1093/infdis/166.3.480
Publikováno v:
Annals of Pharmacotherapy. 30:246-248
OBJECTIVE: To report a case of ticlopidine-induced neutropenia resulting in Pseudomonas bacteremia. CASE SUMMARY: An 83-year-old white man developed febrile neutropenia 5 days after initiation of ticlopidine therapy. At presentation, the patient's wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3607a26accb544ee08e72e03216801a4
https://doi.org/10.1177/106002809603000307
https://doi.org/10.1177/106002809603000307
Publikováno v:
American Journal of Health-System Pharmacy. 52:505-507
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d333a4ba8304e891d825334e691ef09f
https://doi.org/10.1093/ajhp/52.5.505
https://doi.org/10.1093/ajhp/52.5.505
Autor:
Sandra M. Geletko, Mara N. Poulakos
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 59(8)
Pharmaceutical-related interventions in a pharmacist-directed human immunodeficiency virus (HIV) clinic were characterized. Intervention types, clinical significance, and expected outcomes were adapted from the literature. Pharmacists' interventions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993fce4159c106d6febe1530e65470e4
https://pubmed.ncbi.nlm.nih.gov/11977854
https://pubmed.ncbi.nlm.nih.gov/11977854
Autor:
Sandra M. Geletko, Alicia R. ZuWallack
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 58(7)
The treatment of hyperlipidemia in patients infected with HIV is discussed. Hyperlipidemia is common in HIV-infected patients receiving antiretroviral therapy, especially protease inhibitors and stavudine. The recommendations of the National Choleste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72dbcc2bef0a2aa548398de1a6ad847c
https://pubmed.ncbi.nlm.nih.gov/11296612
https://pubmed.ncbi.nlm.nih.gov/11296612
Autor:
Michael N. Dudley, Theresa A. Kennedy, Sandra L. Denman, Sanjeev Kaul, Marcia J. Browne, Kenneth H. Mayer, Kathleen K. Graham, Sandra M. Geletko, Marshall R. Posner, Colin McLaren, Nicola M. Kouttab, Stephen H. Zinner, Gail Skowron, Alan B. Weitberg, Gregory A. Curt, Stephanie B. D. Chafee, Seth M. Steinberg, Lisa M. Dunkle
Publikováno v:
The Journal of infectious diseases. 167(1)
2',3'-didehydro-3'-deoxythymidine (d4T) is a pyrimidine analogue and inhibitor of reverse transcriptase with potent in vitro activity against human immunodeficiency virus (HIV). A phase I trial of d4T was conducted in 41 HIV-infected patients, 12 wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fda74b561b0db886223f11d963c92390
https://pubmed.ncbi.nlm.nih.gov/8093363
https://pubmed.ncbi.nlm.nih.gov/8093363
Autor:
Allan D. Erickson, Sandra M. Geletko
Publikováno v:
Pharmacotherapy. 20:93-94
Combination antiretroviral therapy including protease inhibitors such as ritonavir has added significant potency to therapy for human immunodeficiency viral (HIV) infection as well as substantial drug-drug interactions. Methadone metabolism is affect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b93699b05f3d322bbaf69f139ced8978
https://doi.org/10.1592/phco.20.1.93.34654
https://doi.org/10.1592/phco.20.1.93.34654